Description The purpose of this best practice advice article is to describe the role of Barrett's
endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or …

Esophageal adenocarcinoma (EAC) is rapidly increasing in incidence in Western cultures.
Barrett's esophagus is the presumed precursor lesion for this cancer. Several other risk …

Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Importance Barrett esophagus containing low-grade dysplasia is associated with an
increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly …

Because the esophagus is easily accessible with endoscopy, early diagnosis and curative
treatment of esophageal cancer is possible. However, diagnosis is often delayed because …

Background For endoscopic resection of early GI neoplasia, endoscopic submucosal
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …

Objective Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely
and effectively eradicates Barrett's oesophagus (BO) containing high-grade dysplasia (HGD) …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) can eradicate dysplasia and
intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates …

Background & Aims In patients with Barrett's esophagus (BE), radiofrequency ablation (RFA)
safely and effectively eradicates dysplasia and intestinal metaplasia. We aimed to determine …